Eprosartan Myslate
| CAS No. | 144143-96-4 | Cat. No. | BCP27833 |
| Name | Eprosartan Myslate | ||
| Synonyms | Teveten; Futuran; Navixen; Regulaten; SKF 108566; SKF-108566; | ||
| Formula | C24H28N2O7S2 | M. Wt | 520.62 |
| Description | Eprosartan is an angiotensin II receptor antagonist used for the treatment of high blood pressure. It is marketed in the United States as Teveten by Abbvier. Eprosartan is sometimes paired with hydrochlorothiazide, whereupon it is marketed in the US as Teveten HCT and elsewhere as Teveten Plus.The drug acts on the renin-angiotensin system to decrease total peripheral resistance in two ways. First, it blocks the binding of angiotensin II to AT1 receptors in vascular smooth muscle, causing vascular dilatation. Second, it inhibits sympathetic norepinephrine production, further reducing blood pressure. As with other angiotensin II receptor antagonists, eprosartan is generally better tolerated than enalapril (an ACE inhibitor), especially among the elderly. | ||
| Pathways | GPCR/G Protein | ||
| Targets | Angiotensin Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.